Vannucchi (Sod Hematology Director Careggi), good impact and efficacy of JAK inhibitors on myelofibrosis
(Ruetir) - "For the treatment of chronic myeloproliferative neoplasms, basic therapies, stem cell transplantation and doctor-patient ...
Read more